Bausch Health, Canada is pleased to announce that on November 9, 2022, Arazlo (tazarotene) was added to the Quebec public drug plan formulary (Liste des médicaments de la Régie de… Read More
Simon Fraser University is forging ahead with planning for the first medical school to be built in Western Canada in the last half century. Ten days after being sworn in… Read More
Nimbus Synergies, investor, partner, and mentor to Canada’s leading health technology companies, is pleased to announce the appointment of Jason Robertson as Partner. Jason is a nationally recognized venture capital… Read More
Fourth Interim Analysis Shows Continued Clinically Meaningful Differentiation Across All Efficacy Measures, Including PFS, in Both Domvanalimab-Containing Arms Compared to the Anti-PD-1 Zimberelimab Monotherapy Arm in First-Line NSCLC Patients Data… Read More
“It’s like a Recipe for Other Researchers” VANCOUVER, BC — One of the principles of science is replicability – for a discovery to be considered valid, other researchers must be… Read More
